Calibrated Uncertainty Quantification for Patient-Level AML Drug Sensitivity Prediction Using Split Conformal Prediction
This study introduces a split conformal prediction framework applied to the BeatAML 2.0 cohort that successfully generates statistically calibrated uncertainty intervals for patient-level AML drug sensitivity predictions, revealing distinct uncertainty patterns across drug classes while demonstrating that such uncertainty is independent of standard molecular risk classifications.